PRNewsWire
17 Oct 2025, 23:48 UTC · 48w ago
Verdict
Headline leans bearish. We score BAX −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Baxter International's Novum LVP pumps allegedly suffer from systemic defects causing malfunctions, including under- and over-infusion, leading to patient injury or death.
So whatSerious product safety failures in medical devices typically lead to massive recalls, regulatory sanctions, and loss of market share.
More negative than 99% of claims this week
The lawsuit claims Baxter faced a heightened risk of being forced to take existing Novum LVPs out of service and pause all new sales of the pumps.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 95% of claims this week
A securities fraud class action lawsuit has been filed against Baxter International (BAX) alleging the company misled investors regarding the safety and sales prospects of the Novum LVPs.
More negative than 91% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud class action lawsuit alleging it misled investors regarding systemic defects in its Novum LVP pumps.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
10h ago
+1.7%
Price is moving against the score
$23.48 vs $23.09 close before publication (Oct 17) · not market-adjusted
BAX chart →
